Evidence mapPaperPMID 25420180Full record

SynthesisPediatric research2015

Kidney disease among children in sub-Saharan Africa: systematic review.

Neema M Kayange, Luke R Smart, Jacob E Tallman, Emily Y Chu, Daniel W Fitzgerald, Kevin J Pain, Robert N Peck

Open access · hybridAbstract readSystematic Review
In one paragraph

Synthesis in Pediatric research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Article
  3. UrogenitalOpen forum infectious diseases · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Reducing major risk factors for chronic kidney disease.Kidney international supplements · 2017
    Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Neema M Kayange *Department of Pediatrics, Weill Bugando School of Medicine, Catholic University of Health and Allied Sciences, Mwanza, Tanzania.
Luke R Smart *Department of Internal Medicine, Weill Bugando School of Medicine, Catholic University of Health and Allied Sciences, Mwanza, Tanzania.
Jacob E TallmanCornell University, Ithaca, New York, United States of America.
Emily Y ChuCornell University, Ithaca, New York, United States of America.
Daniel W FitzgeraldCenter for Global Health, Department of Medicine, Weill Cornell Medical College, New York, New York, United States of America.
Kevin J PainSamuel J. Wood Library/CV Starr Biomedical Information Center, Weill Cornell Medical College, New York, New York, United States of America.
Robert N PeckDepartment of Internal Medicine, Weill Bugando School of Medicine, Catholic University of Health and Allied Sciences, Mwanza, Tanzania.
Cornell University · USCatholic University of Health and Allied Sciences · TZCenter for Global Health · US

Funding

Global Health Research Training in HIV and TuberculosisK24AI098627 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI Daniel W Fitzgerald · 2022 to 2022
$181k
FIC NIH HHS R25 TW009337FIC NIH HHS R25TW009337NIAID NIH HHS AI098627NIAID NIH HHS K24 AI098627
6 · The paper itself

Abstract

The global burden of kidney disease is increasing, and several etiologies first begin in childhood. Risk factors for pediatric kidney disease are common in Africa, but data regarding its prevalence are lacking. We completed a systematic review of community-based studies describing the prevalence of proteinuria, hematuria, abnormal imaging, or kidney dysfunction among children in sub-Saharan Africa (SSA). Medline and Embase were searched. Five hundred twenty-three references were reviewed. Thirty-two references from nine countries in SSA were included in the qualitative synthesis. The degree of kidney damage and abnormal imaging varied widely: proteinuria 32.5% (2.2-56.0%), hematuria 31.1% (0.6-67.0%), hydronephrosis 11.3% (0.0-38.0%), hydroureter 7.5% (0.0-26.4%), and major kidney abnormalities 0.1% (0.0-0.8%). Serum creatinine was reported in four studies with insufficient detail to identify the prevalence renal dysfunction. A majority of the studies were performed in Schistosoma haematobium endemic areas. A lower prevalence of kidney disease was observed in the few studies from nonendemic areas. Published data on pediatric kidney disease in SSA are highly variable and dependent on S. haematobium prevalence. More community-based studies are needed to describe the burden of pediatric kidney disease, particularly in regions where S. haematobium infection is nonendemic.

Indexed as

Africa South of the SaharaChildCreatinineHematuriaHumansKidney DiseasesPrevalenceProteinuriaRisk FactorsSchistosomiasis haematobiaCreatinine

Identifiers

PMID25420180
PMCPMC4426498
OpenAlexW2021776608

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.